The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software
Conclusions There was a high prevalence of major DDIs in older adults with cancer. Utilizing clinical decision support software was beneficial for detecting DDIs however, variability existed with severity reporting. Future studies need to identify the relevant DDIs with clinical implications in order to optimize medication safety in this population. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 14, 2018 Category: Cancer & Oncology Source Type: research

Is age a risk factor for depression among the oldest old with cancer?
Discussion Depression among older patients with cancer rises with increasing age, being extremely common among the oldest old. Age independently predicted depression, irrespective of medical variables, social support, or functional status. Findings highlight the importance of addressing the potentially unmet psychological needs of this rapidly growing patient population. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 11, 2018 Category: Cancer & Oncology Source Type: research

The effect of a geriatric evaluation on treatment decisions and outcome for older cancer patients – A systematic review
Conclusion A geriatric evaluation affects oncologic and non-oncologic treatment and appears to improve treatment tolerance and completion for older cancer patients. Fine-tuning the decision-making process for this growing patient population will require more specific and robust data on the effect of a geriatric evaluation on relevant oncologic and non-oncologic outcomes such as survival and quality of life. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 8, 2018 Category: Cancer & Oncology Source Type: research

Beyond the black box of geriatric assessment: Understanding enhancements to care by the geriatric oncology clinic
Conclusion Educational support and comorbidity management are nearly universally offered. Most enhancements to care do not vary by indication for referral. Understanding the enhancements to care provided by geriatric oncology clinics can help with resource planning and program design. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 7, 2018 Category: Cancer & Oncology Source Type: research

Can we incorporate geriatric assessment in the management of acute lymphoblastic leukemia in older adults?
Publication date: Available online 5 April 2018 Source:Journal of Geriatric Oncology Author(s): Kah Poh Loh, Jane L. Liesveld, Kristen M. O'Dwyer Acute lymphoblastic leukemia (ALL) is an uncommon disease. Approximately 14% of new ALL cases occur in adults aged 60 and over, and the three-year overall survival in this population is poor at 12.8%. Older adults with ALL are heterogeneous in terms of their underlying health status, which can make treatment selection challenging given the disease rarity and limited inclusion of older patients in clinical trials. A comprehensive geriatric assessment (CGA) is a compilation of too...
Source: Journal of Geriatric Oncology - April 6, 2018 Category: Cancer & Oncology Source Type: research

Clinical outcomes of endoscopic submucosal dissection for large colorectal laterally spreading tumors in older adults
Conclusions ESD appears to be an effective and safe method for LSTs larger than 3cm in older patients. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Nutritional management of older adults with gastrointestinal cancers: An International Society of Geriatric Oncology (SIOG) review paper
This article aims to provide an overview of the evidence associated with poor nutrition and outcomes in older adults with GI cancers, and recommends a management approach from a geriatric oncologist's perspective. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Update in geriatrics: What geriatric oncology can learn from general geriatric research
Publication date: Available online 1 February 2018 Source:Journal of Geriatric Oncology Author(s): Marije E. Hamaker, Meike Prins, Lieke H. van Huis Life expectancy has been steadily increasing for decades and this trend is likely to continue in coming years. In fact, there is more than a 50% probability that by 2030 female life expectancy could break the 90 year barrier, with more than half of the expected gains due to enhanced longevity above the age of 65 years. The resultant aging of societies means that health care will be faced with a rising number of increasingly older patients, who are also likely to have high...
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Investigation of treatment pattern, medical resource utilization and demographic prognostic factors in older patients with non-Hodgkin lymphoma: A nationwide population-based study
Conclusion Treatment of older patients with NHL is still a challenge. For better outcomes, it is very important to evaluate the patient and tailor treatment modalities. Additionally, health policy makers should help to narrow discrepancies in survival based on demographics. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Melanoma in the very elderly, management in patients 85years of age and over
Conclusions Older patients have thick, mitotically active and frequently ulcerated melanomas. An excision margin≥10mm should be considered to reduce risk of local recurrence. SNB did not impact on survival. With increasing age, patients will more commonly die of causes other than melanoma regardless of the extent of surgical care. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr study
Conclusion The current data suggest that fit older patients with mCRC can be safely treated with a cetuximab-based therapy, as QoL and safety profile do not seem to be affected by age. In addition, age did not impact the choice of chemotherapy to be associated to cetuximab and treatment compliance. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Impact of comorbidity on tolerability and survival following curative intent intensity modulated radiotherapy in older patients with nasopharyngeal cancer
Conclusion Curative IMRT was associated with excellent survival outcomes in older patients with NPC. Comorbidity but not chemotherapy was associated with prognosis in advanced stage. Careful monitoring and intensive support should be instituted in older males with ECOG score ≥2 receiving chemo-radiotherapy. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

The incremental value of a geriatric assessment-derived three-item scale on estimating overall survival in older adults with cancer
Conclusions This three-item scale was a strong independent predictor of survival. If externally validated, this could be a streamlined tool with broader applicability. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Reply to “Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendations” by Mislang et al.
Publication date: Available online 14 February 2018 Source:Journal of Geriatric Oncology Author(s): Olivia Le Saux, Christine Ravot, Elisabeth Castel-Kremer, Claire Falandry (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Short course accelerated radiation therapy (SHARON) in palliative treatment of advanced solid cancer in older patients: A pooled analysis
Conclusion Short course accelerated radiotherapy in locally advanced or metastatic cancers is effective in terms of symptom relief and well tolerated even in older patients. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

How to treat chronic myeloid leukemia (CML) in older adults
Publication date: Available online 18 February 2018 Source:Journal of Geriatric Oncology Author(s): Marlise R. Luskin, Daniel J. DeAngelo Chronic myeloid leukemia (CML), a myeloproliferative neoplasm defined by the t(9;22)(q34;q11) chromosomal translocation, primarily affects older adults. Historically, effective treatment options were not available for older CML patients ineligible for curative allogeneic stem cell transplant, and the disease was therefore usually fatal within several years of diagnosis. The development of tyrosine kinase inhibitors (TKIs) that effectively target the constitutively active mutant tyrosine...
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Assessment of treatment factors and clinical outcomes in cervical cancer in older women compared to women under 65 years old
Conclusions Women over age 65 with cervical cancer are less likely to undergo surgical management and were observed to have a decreased overall survival, even when controlling for use of surgery and stage of disease. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Elucidating the associations between sleep disturbance and depression, fatigue, and pain in older adults with cancer
Conclusions Sleep disturbance is prevalent and often co-occurs with depression, fatigue, or pain in older patients with cancer. Fatigue was significantly associated with sleep disturbance and future studies should explore interventions that target sleep disturbance and fatigue. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Outcomes of postoperative radiation therapy for breast cancer in older women according to age and comorbidity status: An observational retrospective study in 752 patients
Conclusion Postoperative RT for non-metastatic BC in older women is effective and well-tolerated. Outcome is impacted by age and comorbidities, which are clear independent prognostic factors. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Neurocognitive deficits in older patients with cancer
Conclusion Neurocognitive deficits (MCI and dementia) are more common in older adults with cancer. Factors associated with neurocognitive deficits include high comorbidity, stroke, warfarin use and metastatic cancer. Identification and management of these conditions is of great relevance in the course of cancer therapy. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Geriatric assessment-driven polypharmacy discussions between oncologists, older patients, and their caregivers
Conclusion In this secondary analysis, a GA-driven intervention increased PP discussions, particularly about total number of medications and medication management. PP/PIM concerns were more commonly addressed in the intervention group, except for the subset of conversations about supportive care medications. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer
Conclusions Even though frequency and patterns of IrAEs are different from pivotal studies, these results don't seem specific to older patients. Further prospective investigations are needed to better characterize and predict the impact of Nivolumab on older patients with NSCLC. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Preoperative frailty is a risk factor for non-home discharge in patients undergoing surgery for endometrial cancer
Conclusion Frailty is associated with increased risk of non-home discharge in patients undergoing surgery for EMCA. The mFI can be easily calculated using patient characteristics that are readily available pre-operatively. This information can be used for pre-op counseling and to facilitate appropriate and timely discharge planning. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

The impact of changes in radiographic sarcopenia on overall survival in older adults undergoing different treatment pathways for pancreatic cancer
Conclusions In patients who received neoadjuvant chemotherapy, there was a significant decrease in TPAI and HU during treatment. Prospective studies are warranted to assess the impact of TPAI loss and HU changes on clinical outcomes to better individualize treatment pathways based on a patient's fitness. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Geriatric oncology screening tools for CGA-based interventions: results from a phase II study of geriatric assessment and management for older adults with cancer
The objective of this study was to assess the performance of three geriatric oncology screening tools for their ability to predict for CGA-based interventions. Materials and Methods G8, Vulnerable Elders Survey (VES-13) and a modified frailty phenotype (mFP) screening tools were collected prospectively for patients enrolled in a phase II trial of geriatric evaluation and management. Interventions were defined as a new clinical diagnosis, change in management of a comorbidity, or referral to an allied health professional. Performance characteristics were calculated for each screening tool based on the outcomes of ≥2 abno...
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Celebrating a giant in geriatric oncology
Publication date: Available online 12 March 2018 Source:Journal of Geriatric Oncology Author(s): Martine Extermann (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Self-reported major mobility disability and mortality among cancer survivors
Conclusion SR-MMD is an easily ascertainable metric of physical function that is associated with a higher risk of mortality among cancer survivors. Integrating measures of physical function may help to guide clinical decision-making and improve long-term prognostication in this population. Interventions that prevent the development of SR-MDD, such as physical activity, should be evaluated in this population. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

An overview of the toxicities of checkpoint inhibitors in older patients with cancer
This article reviews the tolerability of checkpoint inhibitors in older patients with cancer in clinical practice. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Systematic review of care needs for older patients treated with anticancer drugs
Conclusion Information demand seemed moderate but a great deal of attention was paid to nutrition and well-being. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Significance of stereotactic body radiotherapy in older patients with early stage non-small cell lung cancer
Conclusion SBRT may be effective, even in older adults. Regardless of age, SBRT improved the long-term survival of patients only with G8 scores ≥13. The G8 screening tool may aid in determining whether older patients with comorbidities would benefit from SBRT. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Geriatric radiotherapy in a war-torn country: Experience from Iraq
Conclusions Being the 1st study in this regard in a war-torn nation, Iraq, our results demonstrated that GP is a sizable group of ZCC patients and that RT is a valuable modality in GP cancer treatment. “Age per se” is not a factor to avoid this modality when there is an indication to use it. Longer distance to reach the center was a challenge in some of our GP. Due to inadequate number of RT machines, GP have to wait long time before getting their RT, even for palliative purposes. Further studies in this field are warranted. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST)
Conclusions Our study confirms that current therapy of advanced GIST with tyrosine kinase inhibitors (both in 1st and 2nd line) in older patients enable to achieve the similar disease control rate and final outcomes as in younger patients, but it demands close cooperation of experienced oncologist with patients for dose modifications and side effects management. Limitation of our study is that the patients did not undergo a comprehensive geriatric assessment, what might be helpful for personalized management of patients. Nevertheless, we confirm that older patients with GIST should not receive less treatment irrespective o...
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (alliance)
Conclusions Low chemotherapy preference prior to treatment initiation was associated with lower QoL, worse physical symptoms and self-rated function and more adverse events mid-treatment. There is no association of chemotherapy preference with survival. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Exercise for managing cancer- and treatment-related side effects in older adults
Publication date: Available online 30 March 2018 Source:Journal of Geriatric Oncology Author(s): Kah Poh Loh, Po-Ju Lin, Jacob Uth, Morten Quist, Heidi Klepin, Karen Mustian The incidence of cancer in adults aged 60 years and older is expected to rise, and because cancer is associated with aging, the overall prevalence of cancer will rise as well. With advances in cancer treatment, more older adults will receive treatment but they will also suffer the biopsychosocial consequences of cancer and cancer treatment. In this review, we describe the importance of assessing biopsychosocial needs in this vulnerable population an...
Source: Journal of Geriatric Oncology - April 3, 2018 Category: Cancer & Oncology Source Type: research

Age as a prognostic indicator for adjuvant therapy in patients who underwent pancreatic resections for cancer
Conclusions Regardless of postoperative complications and functional status, age alone appears to affect rates of adjuvant therapy in patients with resected pancreatic cancer. Older patients should be offered tailored regimens that would allow them to complete the intended extent of treatment. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - January 10, 2018 Category: Cancer & Oncology Source Type: research

Treatment of mantle cell lymphoma in older adults
Publication date: Available online 8 January 2018 Source:Journal of Geriatric Oncology Author(s): Daniel F. Pease, Vicki A. Morrison Mantle cell lymphoma (MCL) predominantly affects older adults, with a median age at diagnosis of 70years. A frequently aggressive yet incurable lymphoma, the goal of therapy for MCL is to turn a potentially life-threatening illness into a chronic disease with prolonged periods of remission. Large randomized trial data supports the standard treatment in younger patients of cytarabine-based induction followed by autologous stem cell transplant. Most patients will not be eligible for this inten...
Source: Journal of Geriatric Oncology - January 9, 2018 Category: Cancer & Oncology Source Type: research

Perspective of older African-American and Non-Hispanic white breast cancer survivors from diverse socioeconomic backgrounds toward physical activity: A qualitative study
Conclusion Among older BCS, physical activity preferences were shaped by cancer experience, rather than by race and SES. Physical activity programs for older BCS should focus on addressing cancer treatment-related concerns and should include strength training to ensure PA programs are more acceptable to older BCS. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - January 4, 2018 Category: Cancer & Oncology Source Type: research

Management of older adults with myelodysplastic syndromes (MDS)
Publication date: Available online 29 December 2017 Source:Journal of Geriatric Oncology Author(s): Marlise R. Luskin, Gregory A. Abel The myelodysplastic syndromes (MDS) are a varied group of hematologic neoplasms that lead to bone marrow failure, and also carry a risk of progression to acute myeloid leukemia. Patients with MDS suffer significant impairments to both their quality of life and survival. Age is the dominant risk factor for the development of MDS, with a median age at diagnosis over 70years. Consequently, patients with MDS frequently have concurrent comorbidities and/or frailty which may be coincident or rel...
Source: Journal of Geriatric Oncology - December 30, 2017 Category: Cancer & Oncology Source Type: research

Current systemic therapies for metastatic renal cell carcinoma in older adults: A comprehensive review
Publication date: Available online 15 December 2017 Source:Journal of Geriatric Oncology Author(s): Manuel Caitano Maia, Jacob Adashek, Paulo Bergerot, Lorena Almeida, Simone Fernandes dos Santos, Sumanta K. Pal Physiological changes that occur during the aging process may impact drug metabolism and availability, consequently affecting treatment efficacy and tolerability. Despite being a disease of older adults, there is little data to guide treatment decisions for older patients with metastatic renal cell carcinoma (mRCC). The recent approval of many new agents for this disease poses a clinical challenge: how to best uti...
Source: Journal of Geriatric Oncology - December 16, 2017 Category: Cancer & Oncology Source Type: research

Healthcare experience among older cancer survivors: Analysis of the SEER-CAHPS dataset
Conclusions The SEER-CAHPS data resources allows assessment of factors influencing experience of cancer among U.S. cancer survivors. Higher self-reported health status was associated with better experiences of care; other survivors' characteristics also predicted care experience. Interventions to improve cancer survivors' health status, such as increased access to supportive care services, may improve experience of care. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - December 16, 2017 Category: Cancer & Oncology Source Type: research

Delphi consensus of an expert committee in oncogeriatrics regarding comprehensive geriatric assessment in seniors with cancer in Spain
Conclusion After 3 rounds, consensus was reached regarding CGA domains to be used in older patients with cancer, the scales to be administered for each of these domains, as well as the timeline to be followed during consultation. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - December 14, 2017 Category: Cancer & Oncology Source Type: research

Does my older cancer patient have cognitive impairment?
Publication date: Available online 14 December 2017 Source:Journal of Geriatric Oncology Author(s): Jon Snaedal Cancer and impaired cognition are both frequent conditions in old age and consequently coexist to certain degree. The prevalence of impaired cognition increases sharply after the age of 65 and the more advanced form of cognitive impairment; dementia, is exceeding 30% by the age of 85years. Adequate cognition is crucial for understanding important facts and for giving consent for intervention. There are many different stages of cognitive impairment, ranging from subjective cognitive impairment to severe dementia....
Source: Journal of Geriatric Oncology - December 14, 2017 Category: Cancer & Oncology Source Type: research

Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis
Conclusion In this AGC registry, the use of chemotherapy with schedules adapted to patients ≥70 years provided efficacy that was not inferior to that seen in younger cases, with comparable adverse effects. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - December 12, 2017 Category: Cancer & Oncology Source Type: research

The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436)
Conclusion Obesity was not correlated with adverse relapse or survival outcome, and grade≥3 toxicities were not greater with ABW-based dosing. This supports safety and efficacy of ABW-based dosing as per the 2012 ASCO clinical practice guideline. ClinicalTrials.gov Identifier: NCT00024102 (49907). (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - December 8, 2017 Category: Cancer & Oncology Source Type: research

Trimodality therapy for older patients with bladder cancer: Overtreatment or benefit?
Publication date: Available online 8 December 2017 Source:Journal of Geriatric Oncology Author(s): Marta Bonet, Teresa Bonfill, Miriam Nuñez, Encarna Mur, Meritxell Arenas (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - December 8, 2017 Category: Cancer & Oncology Source Type: research

Moving beyond symptom management towards cancer rehabilitation for older adults: Answering the 5W's
This report utilizes examples of three popular geriatric, distress and symptom measures to help answer these questions. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - December 7, 2017 Category: Cancer & Oncology Source Type: research

Patterns and predictors of emergency department visits among older patients after breast cancer surgery: A population-based cohort study
Conclusion Identification of risk factors in older patients before BC surgery could help prevent postoperative ED visits. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - November 29, 2017 Category: Cancer & Oncology Source Type: research

The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer
Conclusion Our results show that symptom burden and diminished QOL in an older breast cancer population receiving adjuvant TC chemotherapy are short-lived and disappear after a while with no long-term differences compared to a similar population not receiving chemotherapy. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - November 27, 2017 Category: Cancer & Oncology Source Type: research

Brachytherapy for conservative treatment of invasive penile carcinoma in older patients: Single institution experience
Conclusion Brachytherapy is feasible in selected older patients with penile carcinoma, with efficacy and toxicity rates comparable to that of other series in younger patients. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - November 27, 2017 Category: Cancer & Oncology Source Type: research

Recent cancer treatment and memory decline in older adults: An analysis of the 2002 –2012 Health and Retirement Study
Conclusion Our results support a potential association between recent cancer treatment and trajectories of memory decline in older adults and provide guidance on the interpretation of statistical estimates from panel studies of health and aging. (Source: Journal of Geriatric Oncology)
Source: Journal of Geriatric Oncology - November 27, 2017 Category: Cancer & Oncology Source Type: research